UroGen Pharma Ltd. (URGN)
25.73
-3.01
(-10.47%)
USD |
NASDAQ |
Nov 05, 16:00
25.73
0.00 (0.00%)
After-Hours: 06:01
UroGen Pharma SG&A Expense (TTM) : 139.27M for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 139.27M |
| June 30, 2026 | 176.85M |
| March 31, 2026 | 171.62M |
| December 31, 2025 | 155.10M |
| September 30, 2025 | 150.61M |
| June 30, 2025 | 141.96M |
| March 31, 2025 | 98.77M |
| December 31, 2024 | 63.80M |
| September 30, 2024 | 28.94M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Xencor, Inc. | 51.13M |
| MeiraGTx Holdings Plc | 52.16M |
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Viking Therapeutics, Inc. | 62.40M |
| IDEAYA Biosciences, Inc. | 60.68M |